IL17A and chronic obstructive pulmonary disease: Both studies using mice deficient with il17ra14,38, and a clinical study showing the no efficacy of blocking IL-17A to COPD patients39 strongly indicate that inhibition of both IL-17A and IL-17F, or alternative inhibition of their receptor, IL-17RA, may be needed for effective suppression of neutrophilic airway inflammation.